Survival benefit and dynamics of CD8&lt;sup&gt;+&lt;/sup&gt; T cells and tumor-associated macrophages in neoadjuvant immunochemotherapy &lt;i&gt;vs&lt;/i&gt;. This evidence concerns the gene CD8A and neoplasm.